CAR-T cells and other cellular therapies for solid tumors: Current challenges and emerging solutions
Recent advances in cancer immunotherapy have transformed adoptive cellular therapy, yielding remarkable clinical outcomes in hematological malignancies, whereas its efficacy in solid tumors remains severely limited by the immunosuppressive tumor microenvironment, antigen heterogeneity, and on-target/off-tumor toxicitie...